Company
ChinaChongqing Sintaho Pharmaceutical Co., Ltd., China – FDA Inspections
Inspection records and compliance data for Chongqing Sintaho Pharmaceutical Co., Ltd.. 2 FDA inspections on record, 2 Form 483s, last inspected October 31, 2025.
Company Profile
This profile covers Chongqing Sintaho Pharmaceutical Co., Ltd. based in China.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 2
- Form 483s
- 2
- Warning letters
- 0
First inspected August 23, 2024. Last inspected October 31, 2025.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 31, 2025 | Not classified | Human Drugs | 1294996 |
| August 23, 2024 | Not classified | Human Drugs | 1249937 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Other regulators (1)
- China NMPA · 1 inspection · last June 1, 2016
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Shenyang Sunshine Pharmaceutical Co., Ltd.
Shandong Jincheng Bio-Pharmaceutical Co.Ltd
Zibo Xinhua Perrigo Pharmaceutical Co., Ltd.
Huatai Biopharm Inc.
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Jiangsu Weiqida Pharmaceutical Co., Ltd.
Yidu Huayang Chemical Co., Ltd (Zhicheng Factory)
Fujian Nanping Green Pine Chemical Co. Ltd.
Hubei Zhuxi Humanwell Pharmaceutical Co. Ltd.
Hangzhou Hotide Biotech Co Ltd
Company Information
Name
Chongqing Sintaho Pharmaceutical Co., Ltd.
FEI Number
3021637531
Address
China
Country
China
ID: 645edbf9-dbf5-40c7-804c-d1a444bcfcf9